Validation of the new COPD assessment test translated into Thai in patients with chronic obstructive pulmonary disease

BMC Pulmonary Medicine

Charoen Chuchottaworn³  Sumalee Kiatboonsri¹  Chaicharn Pothirat² 

[1] Department of Medicine, Faculty of Medicine, Ramathibodi Hospital, Mahidol University, Bangkok 10400, Thailand;Division of Pulmonary, Critical Care, and Allergy, Department of Internal Medicine, Faculty of Medicine, Chiang Mai University, Chiang Mai 50200, Thailand;Department of Medical Services, Central Chest Institute of Thailand, Ministry of Public Health, Nonthaburi 11000, Thailand

关键词: Validity;    Questionnaire;    Quality of life;    Health status assessment;    Chronic obstructive pulmonary disease;   

Others  :  1091009
DOI  :  10.1186/1471-2466-14-193

 received in 2013-08-08, accepted in 2014-11-20,  发布年份 2014

【 摘 要 】

Background

The COPD Assessment Test (CAT™) is a new questionnaire that has been developed recently for measuring the COPD patient’s health status. It is known to have a good correlation with disease specific health status measured by St. George’s Respiratory Questionnaire (SGRQ). For the wider application in clinical practice, it has been validated in many countries. We evaluated the reliability and validity of the translated CAT questionnaire for Thai COPD patients.

Methods

The study was designed as a cross-sectional validation study enrolling stable Thai COPD patients from three academic centers in Thailand at a single visit. The original CAT questionnaire was translated to Thai through linguistic validation process. The official Thai CAT and SGRQ questionnaires were filled by Thai patients after orientation by the out-patient nurse. The reliability of all items was assessed by Cronbach’s formula for coefficient using pooled data from all patients. The validity of the questionnaire was tested using Pearson’s correlation with SGRQ.

Results

A total of 98 Thai COPD patients completed the official Thai CAT questionnaire; 83% were male, mean age 71 years (SD 8.2), and % predicted of FEV₁ 56.6% (SD 20.9). The official Thai CAT questionnaire was shown to have a high internal consistency (Cronbach's α coefficient = 0.853). The assessment of validity of official Thai CAT questionnaire was moderately correlated with that of SGRQ (r = 0.652).

Conclusions

The official Thai CAT questionnaire has an acceptable reliability and validity. It can be expected to serve as a short and simple tool for assessment of the health status of Thai COPD patients.

【 授权许可】

   
2014 Pothirat et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]GOLD Global Initiative for Chronic Obstructive Lung Disease: Executive summary: global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Update 2010: http://www.goldcopd.org webcite
• [2]Group WHOQOL: Study protocol for the World Health Organization project to develop Quality of Life assessment instruments (WHOQOL). Qual Life Res 1993, 2:153-159.
• [3]Jones PW, Brusselle G, Dal Negro RW, Ferrer M, Kardos P, Levy ML, Perez T, Soler-Cataluna JJ, van der Molen T, Adamek L, Banik N: Health-related quality of life in patients by COPD severity within primary care in Europe. Respir Med 2011, 105:57-66.
• [4]Osman IM, Godden DJ, Friend JA, Legge JS, Douglas JG: Quality of life and hospital re admission in patients with chronic obstructive pulmonary disease. Thorax 1997, 52:67-71.
• [5]Jones PW, Harding G, Wiklund I, Berry P, Leidy N: Improving the process and outcome of care in COPD: development of a standardized assessment tool. Prim Care Respir J 2009, 18:208-215.
• [6]Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Leidy NK: Development and first validation of the COPD Assessment Test. Eur Respir J 2009, 34:648-654.
• [7]McGee H, O’Boyle CA, Hickey A, P’Malley K, Joyce CRB: Assessing the quality of life of the individual: the SEIQol with a healthy and a gastroenterology unit population. Psychol Med 1991, 21:749-759.
• [8]O’Boyle CA, McGee H, Hickey A, O’Malley K, Joyce CRB: Individual quality of life in patients undergoing hip replacement. Lancet 1992, 339:1088-1091.
• [9]Hankinson JL, Odencrantz JR, Fedan KB: Spirometric reference values from a sample of the general US population. Am J RespirCrit Care Med 1999, 159:179-187.
• [10]Hankinson JL, Kawut SM, Shahar E, Smith LJ, Stukovsky KH, Barr RG: Performance of American Thoracic Society-recommended spirometry reference values in a multiethnic sample of adults: the multi-ethnic study of atherosclerosis (MESA) lung study. Chest 2010, 137:138-145.
• [11]Bestall JC, Paul EA, Garrod R, Garnham R, Jones PW, Wedzicha JA: Usefulness of the Medical Research Council (MRC) dyspnoea scale as a measure of disability in patients with chronic obstructive pulmonary disease. Thorax 1999, 54:581-586.
• [12]Meguro M, Elizabeth AB, Spencer S, Jones PW: Development and validation of an improved, COPD-specific version of the St George Respiratory Questionnaire. Chest 2007, 132:456-463.
• [13]Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, Erikson P: Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ISPOR task force for translation and cultural adaptation. Value Health 2005, 8:94-104.
• [14]Cronbach LJ: Coefficient alpha and the internal structure of tests. Psychometrika 1951, 16:297-334.
• [15]TsiligianniI , Van der Molen T, Moraitaki D, Lopez L, Kocks , Karagiannis K, Siafakas N, Tzanakis N: Assessing health status in COPD, a head-to-head comparison between the COPD assessment test (CAT) and the clinical COPD questionnaire (CCQ). BMC Pulm Med 2012, 12:20. BioMed Central Full Text
• [16]Wiklund I, Berry P, Lu KX, Fang J, Fu C: The Chinese translation of COPD assessment test (CAT) provides a valid and reliable measurement of COPD health status in Chinese COPD patients. Am J Respir Crit Care Med 2010, 181:S3575.
• [17]Tsuda T, Suematsu R, Kamohara K, Kurose M, Arakawa I, Tomioka R, Kawayama T, Hoshino T, Aizawa H: Development of the Japanese version of the COPD Assessment Test. Respir Investig 2012, 50:34-39.
• [18]Kwon N, Amin M, Hui DS, Jung K-S, Lim SG, Ta HD, Thai TTL, Yunus F, Jones PW: Validity of the COPD assessment test translated into local languages for Asian Patients. Chest 2013, 143:703-710.
• [19]Celli BR, MacNee W: ATS/ERS Task Force. Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper. Eur Respir J 2004, 23:932-946.
• [20]Zhou QT, Mei JJ, He B, Huang SG, Shi Y, Wen FQ, Zhao MW: Chronic obstructive pulmonary disease assessment test score correlated with dyspnea score in a large sample of Chinese patients. Chin Med J 2013, 126:11-15.
• [21]Dandurand RJ, Bourbeau J, Eidelman DH: Impact of time and symptom scale choice on GOLD grade and correlation of COPD assessment test with FEV1, diffusing capacity and acute exacerbation rate in COPD subjects from community practice. Am J Respir Crit Care Med 2014, 189:A5958.
• [22]Jones PW, Anderson JA, Calverley P, Celli BR, Ferguson GT, Jenkins C, Yates JC, Vestbo J, Spencer MD and for the TORCH investigators: Health status in the TORCH study of COPD: treatment efficacy and other determinants of changes. Respir Res 2011, 12:71. BioMed Central Full Text
• [23]Nunnally JC, Bernstein IH: Psychometric Theory. 3rd edition. New York: McGraw-Hill; 1994.